Better pharmaceutical price comparison studies are needed for meaningful evaluation of price-control policies.
D001315:Australia; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000145:classification / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D038622:Internationality; D014481:United States